Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00385580
Status:
COMPLETED
Last Update Posted:
2013-04-30
First Post:
2006-10-04
Brief Title:
Phase II Study of Dasatinib BMS-354825 for Androgen-deprived Progressive Prostate Cancer
Sponsor:
Organization:
Bristol-Myers Squibb